Inhaled corticosteroids in childhood asthma: Long-term effects on growth and adrenocortical function

Pediatric Drugs

Volumn 5, Issue 6, 2003, Pages 351-361

  Salvatoni, Alessandro ^a   Piantanida, Elena ^a   Nosetti, Luana ^a   Nespoli, Luigi ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; SALMETEROL;

ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL SUPPRESSION; ASTHMA; CHILD GROWTH; CHILDHOOD DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRY POWDER; EPIDEMIOLOGICAL DATA; FOLLOW UP; GROWTH RATE; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LONG TERM CARE; MEDICAL NEBULIZER; METERED DOSE INHALER; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMIC DISEASE;

EID: 0038199816     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200305060-00001     Document Type: Review

References (57)

1. National Asthma Educational Program. Guidelines for the diagnosis and management of asthma. Bethesda (MD): US Department of Health and Human Services, 1998
2. Centers for Disease Control and Prevention. Surveillance for asthma: United States, 1960-1995. MMWR CDC Surveill Summ 1998; 47 Suppl. 1: 1-27
3. Scott TW. Epidemiology and heterogeneity of asthma. Ann Allergy Asthma Immunol 2001; 87 Suppl. 1: 5-8
4. National Institutes of Health. Global strategy for asthma management and prevention. Bethesda (MD): National Institutes of Health, 1995 Jan. NHLBI/WHO workshop report no. 95-3659
5. National Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Washington, DC: National Heart, Lung, and Blood Institute, Expert Panel Report 2, 1997 Jul. NIH Publication No. 97-4051
6. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled steroids and/or beta-2-agonist on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 146: 547-54
7. Hardman JG, Limbird LE, editors. Goodman and Gilman: the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990
8. Johnson M. Pharmacodynamic and pharmacokinetics of inhaled glucocorticosteroids. J Allergy Clin Immunol 1996; 97: 169-76
9. Skoner DP. Balancing safety and efficacy in pediatric asthma management. Pediatrics 2002; 109: 381-92
10. Allen DB. Influence of inhaled steroids on growth: a paediatric endocrinologist's perspective. Acta Paediatr 1998; 87: 123-9
11. Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf 2000; 23: 11-33
12. Colice GL. Comparing inhaled corticosteroids. Respir Care 2000; 45 (7): 846-53
13. Mager DE, Jusko WJ. Quantitative structure-pharmacokinetic/pharmacodynamic relationships of corticosteroids in man. J Pharm Sci 2002; 91 (11): 2441-51
14. English AF, Neate MS, Quint DJ, et al. Biological activities of some corticosteroids used in asthma [abstract]. Am J Respir Crit Care Med 1994; 149: A212
15. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997; 99: 466-74
16. Anhoj J, Bisgaard AM, Bisgaard H. Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma. Pediatrics 2002; 109 (3): E40
17. The transition to CFC-free inhalers: what pharmacists should know. Pharm J 1998; 261: 316-7
18. Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109: 373-80
19. Tinkelman DG, Reed CE, Nelson HS, et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic mild to moderately severe asthma in children. Pediatrics 1993; 92: 64-77
20. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343: 1064-9
21. Cohen MB, Abram LE. Growth pattern of allergic children. J Allergy 1948; 19: 165
22. Ninan TK, Russell G. Asthma, inhaled corticosterolds treatment and growth. Arch Dis Child 1992; 67: 703-5
23. Harter JG, Reddy JR, Thorn GW. Studies on an intermittent corticosteroids dosage regimen. N Engl J Med 1963; 269: 591-6
24. Byron MA, Jackson J, Ansell BM. Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis. J R Soc Med 1983; 76: 452-7
25. Reinberg A, Gervais P, Chaussade M, et al. Circadian changes in effectiveness of corticosteroids in 8 patients with allergic asthma. J Allergy Clin Immunol 1983; 71: 425-33
26. Wolthers OD, Pedersen S. Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children. Allergy 1994; 49: 96-9
27. Heuck C, Wolthers OD, Kollerup G, et al. Adverse effects of inhaled budesonide on growth and collagen turn-over in children with asthma: a double-blind comparison of once-daily versus twice-daily administration. J Pediatr 1998; 133: 608-12
28. Simons FER. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997; 337: 1659-65
29. McCowan C, Neville RG, Thomas GE, et al. Effects of asthma and its treatment on growth: four year follow-up of cohort of children from general practices in Tayside, Scotland. BMJ 1998; 316: 668-72
30. Skoner DP, Szefler SJ, Welch M. et al. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 2000; 105: 259-68
31. Sharek PJ, Bergman DA. The effect of inhaled steroids on linear growth of children with asthma: a meta-analysis. Pediatrics 2000; 106 (1): E8
32. Allen DB, Mullen ML, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994; 93 (6): 967-75
33. American Academy of Allergy, Asthma and Immunology. Pediatric asthma promoting best practice: guide for managing asthma in children. Milwaukee (WI): The American Academy of Allergy Asthma and Immunology Inc, 1999
34. Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995; 151: 1715-9
35. Verberne AA, Frost C, Roorda RJ, et al. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 1997; 156: 688-95
36. Boe J, Bakke P, Rodolen T, et al. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J 1994; 7: 2179-84
37. Ribeiro LB. Budesonide: safety and efficacy aspects of its long-term use in children. Pediatr Allergy Immunol 1993; 4: 73-8
38. Agertoft L, Pedersen S. Effect of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-81
39. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054-63
40. Norjavara E, Gerhardsson de Vermer M, Lindmark B, et al. Reduced height in Swedish man with asthma at the age of conscription for military service. J Pediatr 2000; 6: 25-9
41. Doull IJ, Campbell MJ, Holgate ST. Duration of growth suppressive effect of regular inhaled corticosteroids. Arch Dis Child 1998; 78: 172-3
42. Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. Philadelphia (PA): WB Saunders Company, 2000
43. Wilson JD, Foster DW, Kronenberg HM, et al., editors. Williams textbook of endocrinology. 9th ed. Philadelphia (PA): Saunders Company, 1998
44. Kannisto S, Korppi M, Remes K, et al. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000; 85: 652-7
45. Hartzband PI, Van Herle AJ, Sorger L, et al. Assessment of hypothalamic pituitary adrenal axis dysfunction comparison of ACTH stimulation, insulin hypoglycemia and metyrapone. J Endocrinol Invest 1988; 11: 769-76
46. Stewart PM, Corrie J, Seckl JR, et al. A rational approach for assessing the HPA axis. Lancet 1998; I: 1208-10
47. Bisgaard H, Damkjaer M, Nielsen M, et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol 1988; 81: 1088-95
48. Broide J, Soferman R, Kivity S, et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995; 80 (4): 1243-6
49. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148: S1-17
50. Volovitz B, Amir J, Malik H, et al. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 1993; 329: 1703-8
51. Clark DJ, Lipworth BJ, Clark RA. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax 1996; 51: 941-3
52. Goldberg S, Algur N, Levi M, et al. Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroids with and without spacer device. Ann Allergy Asthma Immunol 1996; 76 (3): 234-8
53. Ninan TK, Reid IW, Carter PE, et al. Effective high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Thorax 1993; 48: 599-602
54. Brown PH, Blundell G, Greening A, et al. Screening for HPA axis suppression in asthmatics taking high dose inhaled glucocorticosteroids. Respir Med 1991; 85: 511-22
55. Wolthers OD, Pedersen S. Measures of systemic activity of inhaled corticosteroids in children: a comparison of urine cortisol excretion and knemometry. Respir Med 1995; 89: 347-9
56. Patel L, Wales JK, Kibirige MS, et al. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child 2001; 85: 330-4
57. Suissa S, Ernst P, Benayoun S. et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332-6